Advertisement

Clinical Rheumatology

, Volume 38, Issue 12, pp 3451–3458 | Cite as

Nailfold videocapillaroscopy alterations in dermatomyositis, antisynthetase syndrome, overlap myositis, and immune-mediated necrotizing myopathy

  • Caroline SoubrierEmail author
  • Julie Seguier
  • Marie-Pierre Di Costanzo
  • Mikael Ebbo
  • Emmanuelle Bernit
  • Estelle Jean
  • Véronique Veit
  • Laure Swiader
  • Emmanuelle Salort-Campana
  • Shahram Attarian
  • André Maues De Paula
  • Gilles Kaplanski
  • Jean-Marc Durand
  • Jean-Robert Harlé
  • Nicolas Schleinitz
Original Article

Abstract

Introduction/objectives

The aim of our study was to investigate possible differences in nailfold videocapillaroscopy (NVC) features between patients with dermatomyositis (DM), overlap myositis (OM), antisynthetase syndrome (ASS), and immune-mediated necrotizing myopathy (IMNM).

Methods

We performed a cross-sectional monocentric study. All patients with inflammatory myopathies (IMs) over a 6-month period were analyzed by NVC for giant and ramified capillaries, tortuosities, capillary density, disorganization, and scleroderma pattern. Clinical, biological, and pathological characteristics were retrospectively recorded. Patients were classified as having DM, OM, ASS, or IMNM for comparison. Patients were also compared with a group of patients with systemic sclerosis (SSc).

Results

NVC was analyzed in DM (n = 17), OM (n = 8), ASS (n = 12), and IMNM (n = 6). Vascular disorganization and avascular zones were observed only in DM (11.8%) and OM (62.5%). The percentage of patients with giant capillaries was higher in OM (n = 4/8) than in DM (n = 3/17) and absent in ASS and IMNM. Frequency of ramified capillaries, tortuosities, hemorrhages, or thrombosis was not different between subgroups. A scleroderma pattern was only observed in OM patients.

Conclusion

In this limited series of patients, we observed that DM and OM NVC abnormalities are different from ASS and IMNM. We could not determine NVC specific patterns associated with myositis-specific antibody subtypes of DM because of the small number of patients.

Key Points

• Nailfold videocapillaroscopy abnormalities are different in subgroups of inflammatory myopathies.

• Giant capillaries, disorganization, and major capillary loss are observed in overlap myositis and dermatomyositis but not in antisynthetase syndrome (ASS) or immune-mediated necrotizing myopathy.

• Nailfold videocapillaroscopy abnormalities in overlap myositis (with the exclusion of ASS) are close to systemic sclerosis.

Keywords

Antisynthetase syndrome Dermatomyositis Immune-mediated necrotizing myopathy Inflammatory myopathies Nailfold capillaroscopy Overlap myositis 

Notes

Acknowledgments

We thank Pr Nathalie Bardin for providing results for autoantibodies testing and Pr Christophe Chagnaud for magnetic resonance imaging in IMs patients.

Compliance with ethical standards

The study was performed in accordance with the ethical standards of the Helsinki Declaration. According to the French law (no. 2004–806, August 9, 2004), and because the data were collected retrospectively and patient management was not modified, this study did not require a specific research ethics committee approval.

Disclosures

Nones.

References

  1. 1.
    van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Müller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Csuka ME, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE (2013) 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative: ACR/EULAR Classification Criteria for SSc. Arthritis Rheum 65:2737–2747.  https://doi.org/10.1002/art.38098 CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Cutolo M, Sulli A, Pizzorni C, Accardo S (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27:155–160PubMedGoogle Scholar
  3. 3.
    Soulaidopoulos S, Triantafyllidou E, Garyfallos A, Kitas GD, Dimitroulas T (2017) The role of nailfold capillaroscopy in the assessment of internal organ involvement in systemic sclerosis: a critical review. Autoimmun Rev 16:787–795.  https://doi.org/10.1016/j.autrev.2017.05.019 CrossRefPubMedGoogle Scholar
  4. 4.
    Smith V, Decuman S, Sulli A, Bonroy C, Piettte Y, Deschepper E, de Keyser F, Cutolo M (2012) Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? A pilot study. Ann Rheum Dis 71:1636–1639.  https://doi.org/10.1136/annrheumdis-2011-200780 CrossRefPubMedGoogle Scholar
  5. 5.
    Ingegnoli F, Ardoino I, Boracchi P, Cutolo M, Airò P, Ananieva LP, Ancuta C, Andrade LE, Becvar R, Benenati A, Caramaschi P, Carreira PE, Cuomo G, Damjanov N, Distler O, Foti R, Guiducci S, Hachulla E, Highton J, Kayser C, Lubatti C, Cerinic MM, Meier F, Meroni PL, Mihai CM, Morgiel E, Müller-Ladner U, Loyo E, Ortiz V, Riccieri V, Scheja A, Skacelova S, Smith V, Stamenkovic B, Stebbings S, Stoica V, Sulli A, Szechinski J, Tyndall A, Valentini G, Walker U, Zeni S, Zlatanovic M (2013) Nailfold capillaroscopy in systemic sclerosis: data from the EULAR scleroderma trials and research (EUSTAR) database. Microvasc Res 89:122–128.  https://doi.org/10.1016/j.mvr.2013.06.003 CrossRefPubMedGoogle Scholar
  6. 6.
    Lee P, Leung FY, Alderdice C, Armstrong SK (1983) Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment. J Rheumatol 10:930–938PubMedGoogle Scholar
  7. 7.
    Ingegnoli F, Ughi N, Crotti C, Mosca M, Tani C (2017) Outcomes, rates and predictors of transition of isolated Raynaud’s phenomenon: a systematic review and meta-analysis. Swiss Med Wkly 147.  https://doi.org/10.4414/smw.2017.14506
  8. 8.
    Maricq HR, Weinberger AB, LeRoy EC (1982) Early detection of scleroderma-spectrum disorders by in vivo capillary microscopy: a prospective study of patients with Raynaud’s phenomenon. J Rheumatol 9:289–291PubMedGoogle Scholar
  9. 9.
    Maricq HR, Harper FE, Khan MM, Tan EM, LeRoy E (1983) Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease. Clin Exp Rheumatol 1:195–205PubMedGoogle Scholar
  10. 10.
    Cutolo M, Sulli A, Secchi ME, Olivieri M, Pizzorni C (2007) The contribution of capillaroscopy to the differential diagnosis of connective autoimmune diseases. Best Pract Res Clin Rheumatol 21:1093–1108.  https://doi.org/10.1016/j.berh.2007.10.001 CrossRefPubMedGoogle Scholar
  11. 11.
    Szabo N, Csiki Z, Szanto A, Danko K, Szodoray P, Zeher M (2008) Functional and morphological evaluation of hand microcirculation with nailfold capillaroscopy and laser Doppler imaging in Raynaud’s and Sjögren’s syndrome and poly/dermatomyositis. Scand J Rheumatol 37:23–29.  https://doi.org/10.1080/03009740701640209 CrossRefPubMedGoogle Scholar
  12. 12.
    Maricq HR, LeRoy EC (1973) Patterns of finger capillary abnormalities in connective tissue disease by “wide-field” microscopy. Arthritis Rheum 16:619–628CrossRefGoogle Scholar
  13. 13.
    Bertolazzi C, Cutolo M, Smith V, Gutierrez M (2017) State of the art on nailfold capillaroscopy in dermatomyositis and polymyositis. Semin Arthritis Rheum 47:432–444.  https://doi.org/10.1016/j.semarthrit.2017.06.001 CrossRefPubMedGoogle Scholar
  14. 14.
    Troyanov Y, Targoff IN, Tremblay J-L, Goulet JR, Raymond Y, Senécal JL (2005) Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine (Baltimore) 84:231–249CrossRefGoogle Scholar
  15. 15.
    Benveniste O, Stenzel W, Allenbach Y (2016) Advances in serological diagnostics of inflammatory myopathies. Curr Opin Neurol 29:662–673.  https://doi.org/10.1097/WCO.0000000000000376 CrossRefPubMedGoogle Scholar
  16. 16.
    Mariampillai K, Granger B, Amelin D, Guiguet M, Hachulla E, Maurier F, Meyer A, Tohmé A, Charuel JL, Musset L, Allenbach Y, Benveniste O (2018) Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies. JAMA Neurol 75:1528–1537.  https://doi.org/10.1001/jamaneurol.2018.2598 CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Maricq HR, Spencer-Green G, LeRoy EC (1976) Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud’s syndrome and dermatomyositis. Am J Med 61:862–870CrossRefGoogle Scholar
  18. 18.
    Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. N Engl J Med 292:344–347.  https://doi.org/10.1056/NEJM197502132920706 CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Matsushita T, Hasegawa M, Fujimoto M et al (2007) Clinical evaluation of anti-aminoacyl tRNA synthetase antibodies in Japanese patients with dermatomyositis. J Rheumatol 34:1012–1018PubMedGoogle Scholar
  20. 20.
    Hamaguchi Y, Fujimoto M, Matsushita T, Kaji K, Komura K, Hasegawa M, Kodera M, Muroi E, Fujikawa K, Seishima M, Yamada H, Yamada R, Sato S, Takehara K, Kuwana M (2013) Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome. PLoS One 8:e60442.  https://doi.org/10.1371/journal.pone.0060442 CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Marguerie C, Bunn CC, Beynon HL et al (1990) Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med 77:1019–1038CrossRefGoogle Scholar
  22. 22.
    Mercer LK, Moore TL, Chinoy H, Murray AK, Vail A, Cooper RG, Herrick AL (2010) Quantitative nailfold video capillaroscopy in patients with idiopathic inflammatory myopathy. Rheumatology (Oxford) 49:1699–1705.  https://doi.org/10.1093/rheumatology/keq051 CrossRefGoogle Scholar
  23. 23.
    Allenbach Y, Benveniste O, Goebel H-H, Stenzel W (2017) Integrated classification of inflammatory myopathies. Neuropathol Appl Neurobiol 43:62–81.  https://doi.org/10.1111/nan.12380 CrossRefPubMedGoogle Scholar
  24. 24.
    Mescam-Mancini L, Allenbach Y, Hervier B, Devilliers H, Mariampillay K, Dubourg O, Maisonobe T, Gherardi R, Mezin P, Preusse C, Stenzel W, Benveniste O (2015) Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis. Brain 138:2485–2492.  https://doi.org/10.1093/brain/awv192 CrossRefPubMedGoogle Scholar
  25. 25.
    Kubo S, Todoroki Y, Nakayamada S, Nakano K, Satoh M, Nawata A, Satoh Y, Miyagawa I, Saito K, Smith V, Cutolo M, Tanaka Y (2019) Significance of nailfold videocapillaroscopy in patients with idiopathic inflammatory myopathies. Rheumatology (Oxford) 58:120–130.  https://doi.org/10.1093/rheumatology/key257 CrossRefGoogle Scholar
  26. 26.
    Selva-O’Callaghan A, Fonollosa-Pla V, Trallero-Araguás E et al (2010) Nailfold capillary microscopy in adults with inflammatory myopathy. Semin Arthritis Rheum 39:398–404.  https://doi.org/10.1016/j.semarthrit.2008.09.003 CrossRefPubMedGoogle Scholar
  27. 27.
    Sebastiani M, Triantafyllias K, Manfredi A, González-Gay MA, Palmou-Fontana N, Cassone G, Drott U, Delbrück C, Rojas-Serrano J, Bertolazzi C, Nuño L, Giannini M, Iannone F, Vicente EF, Castañeda S, Selva-O’Callaghan A, Trallero Araguas E, Emmi G, Iuliano A, Bauhammer J, Miehle N, Parisi S, Cavagna L, Codullo V, Montecucco C, Lopez-Longo FJ, Martínez-Barrio J, Nieto-González JC, Vichi S, Confalonieri M, Tomietto P, Bergner R, Sulli A, Bonella F, Furini F, Scirè CA, Bortoluzzi A, Specker C, Barsotti S, Neri R, Mosca M, Caproni M, Weinmann-Menke J, Schwarting A, Smith V, Cutolo M, The American and European Network of Antisynthetase Syndrome Collaborative Group (2019) Nailfold capillaroscopy characteristics of antisynthetase syndrome and possible clinical associations: results of a multicenter international study. J Rheumatol 46:279–284.  https://doi.org/10.3899/jrheum.180355 CrossRefGoogle Scholar
  28. 28.
    Pavlov-Dolijanovic S, Damjanov NS, Stojanovic RM, Vujasinovic Stupar NZ, Stanisavljevic DM (2012) Scleroderma pattern of nailfold capillary changes as predictive value for the development of a connective tissue disease: a follow-up study of 3,029 patients with primary Raynaud’s phenomenon. Rheumatol Int 32:3039–3045.  https://doi.org/10.1007/s00296-011-2109-2 CrossRefPubMedGoogle Scholar
  29. 29.
    Manfredi A, Sebastiani M, Campomori F, Pipitone N, Giuggioli D, Colaci M, Praino E, Ferri C (2016) Nailfold videocapillaroscopy alterations in dermatomyositis and systemic sclerosis: toward identification of a specific pattern. J Rheumatol 43:1575–1580.  https://doi.org/10.3899/jrheum.160122 CrossRefPubMedGoogle Scholar
  30. 30.
    Bergman R, Sharony L, Schapira D, Nahir MA, Balbir-Gurman A (2003) The handheld dermatoscope as a nail-fold capillaroscopic instrument. Arch Dermatol 139:1027–1030.  https://doi.org/10.1001/archderm.139.8.1027 CrossRefPubMedGoogle Scholar
  31. 31.
    De Angelis R, Cutolo M, Gutierrez M et al (2012) Different microvascular involvement in dermatomyositis and systemic sclerosis. A preliminary study by a tight videocapillaroscopic assessment. Clin Exp Rheumatol 30:S67–S70PubMedGoogle Scholar
  32. 32.
    Manfredi A, Sebastiani M, Cassone G, Pipitone N, Giuggioli D, Colaci M, Salvarani C, Ferri C (2015) Nailfold capillaroscopic changes in dermatomyositis and polymyositis. Clin Rheumatol 34:279–284.  https://doi.org/10.1007/s10067-014-2795-8 CrossRefPubMedGoogle Scholar

Copyright information

© International League of Associations for Rheumatology (ILAR) 2019

Authors and Affiliations

  • Caroline Soubrier
    • 1
    Email author
  • Julie Seguier
    • 1
    • 2
  • Marie-Pierre Di Costanzo
    • 1
  • Mikael Ebbo
    • 1
    • 2
  • Emmanuelle Bernit
    • 1
  • Estelle Jean
    • 1
  • Véronique Veit
    • 1
  • Laure Swiader
    • 1
  • Emmanuelle Salort-Campana
    • 3
  • Shahram Attarian
    • 2
    • 3
  • André Maues De Paula
    • 3
  • Gilles Kaplanski
    • 2
    • 4
  • Jean-Marc Durand
    • 1
    • 2
  • Jean-Robert Harlé
    • 1
    • 2
  • Nicolas Schleinitz
    • 1
    • 2
  1. 1.Department of Internal Medicine AP-HMHopital TimoneMarseille cedexFrance
  2. 2.Aix-Marseille UniversityMarseilleFrance
  3. 3.Referral Center for Neuromuscular Diseases and ALS AP-HMMarseilleFrance
  4. 4.Department of Internal Medicine AP-HMHopital ConceptionMarseilleFrance

Personalised recommendations